Clinical outcomes of patients with idiopathic anaphylaxis receiving omalizumab

被引：0
|
作者：
Kaminsky, Lauren [1 ]
Aukstuolis, Kestutis [2 ]
Petroni, Daniel [3 ]
Al-Shaikhly, Taha [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Northwest Asthma Allergy Ctr, Washington, DC USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
049
引用
收藏
页码：AB16 / AB16
页数：1
相关论文
共 50 条
  • [1] OMALIZUMAB IN IDIOPATHIC ANAPHYLAXIS
    Warrier, Priya
    Casale, Thomas B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 102 (03) : 257 - 258
  • [2] Treatment of idiopathic anaphylaxis with omalizumab
    Sanchez-Valenzuela, Maria C.
    Garcia-Saucedo, Juan C.
    Motoa, Gabriel
    Carrillo-Martin, Ismael
    Gonzalez-Estrada, Alexei
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (06) : 612 - 613
  • [3] Prevention of Anaphylaxis Episodes in Idiopathic Anaphylaxis by Omalizumab
    Kosnik, Mitja
    Zugan, Lea
    Rijavec, Matija
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (08) : 761 - 766
  • [4] Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience
    Harrison, Rachel G.
    MacRae, Megan
    Karsh, Jacob
    Santucci, Stephanie
    Yang, William H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (01) : 77 - 78
  • [5] Successful treatment of idiopathic anaphylaxis with omalizumab
    Jones, J. D.
    Marney, S.
    Fahrenholz, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A34 - A34
  • [6] IDIOPATHIC ANAPHYLAXIS SUCCESSFULLY TREATED WITH OMALIZUMAB
    Jones, Jeremy D.
    Marney, Samuel R., Jr.
    Fahrenholz, John M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (05) : 550 - 551
  • [7] Omalizumab for idiopathic anaphylaxis-a case series
    Kolar, P.
    Kokelj, S.
    Zidarn, M.
    Erzen, R.
    Bajrovic, N.
    Kopac, P.
    Silar, M.
    Korosec, P.
    Kosnik, M.
    [J]. ALLERGY, 2017, 72 : 505 - 505
  • [8] Promising option in the prevention of idiopathic anaphylaxis: Omalizumab
    Demirturk, Mustafa
    Gelincik, Asli
    Colakoglu, Bahattin
    Dal, Murat
    Buyukozturk, Suna
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (06): : 552 - 554
  • [9] Use of omalizumab in idiopathic anaphylaxis in a 16 year old
    Kyin, T.
    Boyce, J. A.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (05) : 481 - 481
  • [10] Favorable outcome of omalizumab treatment in a patient with idiopathic anaphylaxis
    Ban, Ga-Young
    Yang, Eun-Mi
    Kim, Ji-Hye
    Shin, Yoo-Seob
    Ye, Young-Min
    Nahm, Dong-Ho
    Park, Hae-Sim
    [J]. ALLERGY ASTHMA & RESPIRATORY DISEASE, 2015, 3 (05): : 380 - 383
12345